Takeda stock pre-market at EUR 16.55
Published on 10/07/2026 at 08:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Takeda stock was at EUR 16.55 in pre-market trading at Lang & Schwarz at 8:18 a.m. CEST on October 7, 2026.
Pre-market trading
Lang & Schwarz showed a bid of EUR 16.00 and an ask of EUR 17.10. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Takeda stock.
Oncology data planned for ESMO
In a September 22, 2026, release, Takeda said it will present new oncology pipeline and portfolio data at the European Society for Medical Oncology Congress in Madrid from October 23 to October 27, 2026.
The company said the presentations will include late-breaking Phase 3 data on arcotatug tavatecan in previously treated advanced gastric or gastroesophageal junction adenocarcinoma, as well as findings on TAK-928 in non-small cell lung cancer. Takeda also said it will expand the global Phase 3 MarsLight-11 study with a sub-trial for patients with non-squamous non-small cell lung cancer.
